Showkat Ahmad Bhat | Cancer Biology | Best Researcher Award

Dr.Showkat Ahmad Bhat | Cancer Biology | Best Researcher Award

Associate professor, Govt. Medical College Handwara 

Dr. Showkat Ahmad Bhat is an Associate Professor in the Department of Biochemistry at Govt. Medical College (GMC) Handwara & Associated Hospitals, Jammu & Kashmir, India. With extensive experience in clinical biochemistry and molecular biology, his research focuses on cancer biology, proteomics, and epigenetics. He has held various academic and administrative roles in reputed institutions, including GMC Srinagar, GMC Doda, and Al-Falah School of Medical Science & Research Centre. Dr. Bhat has actively contributed to scientific research through multiple funded projects and has received prestigious fellowships from ICMR and CSIR. His expertise extends to communicable diseases, parasitic resistance, and biochemical laboratory techniques. A passionate educator and researcher, he has presented at national and international conferences, winning awards for his contributions to cancer diagnostics and molecular research. His work is dedicated to advancing medical science through innovative biochemical methodologies and fostering academic excellence in medical education.

Profile

Scholar

 Education 

Ph.D. in Biochemistry – BU Rajasthan, Sikar Road, Ajmer M.Sc. in Clinical Biochemistry – University of Kashmir Six-month Internship – Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar B.Sc. in Medical Sciences – S.P. College, Srinagar, Kashmir University  Computer Diploma – NCPUL and DOEACC, Ministry of HRD & IT, Centre Budgam 12th Class (Medical Stream) – Jammu & Kashmir Board of School Education, Srinagar

 Experience 

Associate Professor (2023–Present) – GMC Handwara & Associated Hospitals, Jammu & Kashmir Assistant Professor (2023) – GMC Handwara & Associated Hospitals, Jammu & Kashmir Assistant Professor (2022–2023) – Al-Falah School of Medical Science & Research Centre, Haryana Assistant Professor (2019–2022) – GMC Doda & Associated Hospitals, Jammu & Kashmir Demonstrator/Tutor (2017–2019) – GMC Srinagar, Jammu & Kashmir Research Fellow (2008–2017) – Various ICMR and DST-funded projects on cancer biomarkers, epigenetics, and molecular diagnostics Administrative Roles (2018–Present) – Curriculum Coordinator, Lab Coordinator, IT & Biometric In-Charge, Academic Section Head, Hostel Warden

Awards & Honors 

ICMR Grant (2019) – Workshop on Biochemical Laboratory Techniques CSIR Research Associateship (2017) – RA-3 Scheme Fello DST Travel Grant (2015, 2014, 2013) – Attended international and national conferences, including the 101st & 100th Indian Science Congress Best Oral Presentation Award (2015) – National Conference BIOCME on Advances in Biochemical & Molecular Diagnostics RCR Ross Prize Entrant (2013) – Methylation Status Study in Colorectal Cancer (UK Conference) ICMR Senior Research Fellowship (2013) – Molecular Cancer Diagnostics Various Prestigious Fellowships & Grants – Recognized for outstanding contributions to cancer biomarker research and molecular biochemistry

 Research Focus 

Cancer Biology – Early diagnostic markers, epigenetic modifications, and molecular profiling in gastric and colorectal cancer  Clinical Biochemistry – Biomarkers in disease progression and metabolic disorders Proteomics & Molecular Biology – Protein expression analysis for disease characterization Epigenetics – DNA methylation and gene regulation in carcinogenesis Communicable Diseases – Molecular mechanisms of infectious disease resistance Parasitic Resistance – Studying biochemical adaptations in parasitic infections Biochemical Diagnostics – Development of novel techniques for improved disease detection and treatment strategies

Conclusion

Dr. Showkat Ahmad Bhat’s extensive research experience, significant grants and fellowships, high-quality publications, and innovative projects make him a strong candidate for the Best Researcher Award. Addressing the identified areas for improvement could further enhance his candidacy and contribute to his professional growth.

Puplication

  • Bilal Ahmad, SB., Rehman, M.U., Amin, I., Arif, A., Rasool, S., et al. (2015). “A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).” The Scientific World Journal, 1-6. (281 citations)

 

  • Bhat, S.A., Hassan, T., Majid, S. (2019). “Heavy metal toxicity and their harmful effects on living organisms–a review.” International Journal of Medical Science And Diagnosis Research, 3(1), 106-122. (100 citations)

 

  • Dar, RASNAG M.A., Ahmad, S.M., Bhat, S.A., Ahmed, R., Urwat, U., Mumtaz, P.T., et al. (2017). “Salmonella typhimurium in poultry: a review.” World’s Poultry Science Journal, 73(2), 345-3. (90 citations)

 

  • Bashir, A.H., Bhat, S.A., Majid, S., Hamid, R., et al. (2020). “Role of inflammatory mediators (TNF-α, IL-6, CRP), biochemical and hematological parameters in type 2 diabetes mellitus patients of Kashmir, India.” Medical Journal of the Islamic Republic of Iran (MJIRI), 34(5), 1-6. (74 citations)

 

  • Reshi, A.A., Husain, I., Bhat, S.A., Rehman, M.U., Razak, R., et al. (2015). “Bovine mastitis as an evolving disease and its impact on the dairy industry.” IJCRR, 7(5), 48-55. (66 citations)

 

  • Rehman, M.U., Rashid, S.M., Rasool, S., Shakeel, S., Ahmad, B., Ahmad, S.B., et al. (2019). “Zingerone (4-(4-hydroxy-3-methylphenyl) butan-2-one) ameliorates renal function via controlling oxidative burst and inflammation in experimental diabetic nephropathy.” Archives of Physiology and Biochemistry, 125(3), 201-209. (58 citations)

 

  • Bhat, S.A., Mir, M.U.R., Qadir, S., Mehraj, I., et al. (2012). “Prevalence of gastro-intestinal parasitic infections in Sheep of Kashmir valley of India.” Veterinary World, 5(11), 667-671. (48 citations)

 

  • Bhat, S.A., Saravanan, P., Hosamani, M., Basagoudanavar, S.H., et al. (2013). “Novel immunogenic baculovirus expressed virus-like particles of foot-and-mouth disease (FMD) virus protect guinea pigs against challenge.” Research in Veterinary Science, 95(3), 1217-1223. (45 citations)

 

  • Ahmad, S.B., Rehman, M.U., Fatima, B., Ahmad, B., et al. (2017). “Antifibrotic effects of D-limonene (5(1-methyl-4-[1-methylethenyl]) cyclohexane) in CCl-induced liver toxicity in Wistar rats.” Environmental Toxicology, 1-9. (39 citations)

 

  • Malik, M.A., Bhat, S.A., Fatima, B., Ahmad, S.B., Sidiqui, S., Shrivastava, P. (2016). “Rheum emodi as a valuable medicinal plant.” International Journal of General Medicine and Pharmacy, 5(4), 35-44. (32 citations)

 

  • Bhat, S.A., Majid, S., Wani, H.A., Rashid, S. (2019). “Diagnostic utility of epigenetics in breast cancer–a review.” Cancer Treatment and Research Communications, 19, 100125. (30 citations)

 

  • Bhat, S.A., Mir, M.R., Majid, S., Reshi, A.A., Husain, I., Hassan, T., Ahmad, H. (2019). “Serum lipid profile of breast cancer patients in Kashmir.” (Journal details not provided). (Citation count not mentioned)

 

Ashwani Patil | Cancer Biology | Best Scholar Award

Dr. Ashwani Patil | Cancer Biology | Best Scholar Award

Assistant Professor, Dr. D. Y. Patil Institute of Pharmaceutical Sciences & Research India

Dr. Ashwani Patil is a passionate pharmacologist specializing in neurological disorders and cancer research. He completed his Ph.D. in Pharmacology from the Institute of Chemical Technology (ICT), Mumbai, with a focus on preclinical drug development. His research at Bhabha Atomic Research Centre and NIRRH Mumbai deepened his expertise in molecular mechanisms underlying complex diseases. With hands-on experience in animal handling, molecular techniques, and pharmacological testing, he has contributed significantly to understanding disease pathology and potential therapeutic targets for cancer and neurological disorders.

Professional Profile 

Scopus

Scholar

🎓Education

Ph.D. in Pharmaceutical Tech. (Pharmacology), Institute Of Chemical Technology, Mumbai (2024). M. Pharmacy (Pharmacology), R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018). Bachelor of Pharmacy, A.R.A College of Pharmacy, Dhule (2016)

💼Experience

Junior Research Fellow, R.C. Patel Institute of Pharmaceutical Education and Research, Shirpur (2018-2019). Research Scholar, Institute of Chemical Technology, Mumbai (2022-Present). Assistant Professor, Dr. D Y Patil Institute of Pharmaceutical Science and Research, Pune (2019-2020, 2024). Expertise in preclinical drug studies, rodent surgery, data analysis, and project planning.

🏆Award and Honor

DAE-ICT Fellowship, 2024. 1st Position in Poster Presentation, 7th International Conference on “Emerging Trends in Drug Development and Delivery” (2024). Research Excellence Award, GEU, Dehradun (2015). Best Paper Presentation Award, TriboIndia 2023, NIT Srinagar

🔬 Research Focus

Dr. Patil’s research spans preclinical drug development, focusing on neurological disorders and cancer. His work investigates therapeutic targets, pharmacodynamics, and the molecular mechanisms of disease pathology. Key areas of interest include rodent models, drug efficacy, safety profiles, and mitochondrial toxicity. His publications highlight cancer cell cytotoxicity and cardioprotective effects, contributing to the understanding of pharmacological agents in disease treatment.

Publications Top Noted

1. Title: Cardioprotective effect of CB1 receptor antagonist AM251 against β receptor-stimulated myocardial infarction via modulation of NF-kB signaling pathway in diabetic mice

Year: 2024
Authors: Pawar, H.D., Patil, Y., Patil, A., Ojha, S., Goyal, S.N.
Citation: Heliyon, 10(15), e35138
Citations: 0

2. Title: Mitochondria-targeted derivative of pterostilbene, a dietary phytoestrogen, exhibits superior cancer cell cytotoxicity via mitochondrial superoxide mediated induction of autophagy

Year: 2023
Authors: Ibrahim, M.K., Nandha, S.R., Patil, A.S., Sharma, D., Sandur, S.K.
Citation: Advances in Redox Research, 8, 100071
Citations: 1

3. Title: Mitochondriotropic Derivative of Ethyl Ferulate, a Dietary Phenylpropanoid, Exhibits Enhanced Cytotoxicity in Cancer Cells via Mitochondrial Superoxide-Mediated Activation of JNK and AKT Signalling

Year: 2023
Authors: Patil, A.S., Ibrahim, M.K., Sathaye, S., Sharma, D., Sandur, S.K.
Citation: Applied Biochemistry and Biotechnology, 195(3), 2057–2076
Citations: 2

4. Title: Plant-derived natural therapeutics targeting cannabinoid receptors in metabolic syndrome and its complications: A review

Year: 2020
Authors: Patil, A.S., Mahajan, U.B., Agrawal, Y.O., Sharma, C., Goyal, S.N.
Citation: Biomedicine and Pharmacotherapy, 132, 110889
Citations: 17

5. Title: Protective effect of omeprazole and lansoprazole on β-receptor stimulated myocardial infarction in Wistar rats

Year: 2019
Authors: Patil, A.S., Singh, A.D., Mahajan, U.B., Ojha, S., Goyal, S.N.
Citation: Molecular and Cellular Biochemistry, 456(1-2), 105–113
Citations: 17

 

Jessica Abene| Oncology| Best Researcher Award

Ms. Jessica Abene| Oncology| Best Researcher Award

Ms. University of Pennsylvania,  United States

Jessica Abene is a dedicated nursing professional with a passion for advancing healthcare through evidence-based research. She earned her Bachelor of Nursing Science (BSN) from the University of Pennsylvania in 2023 and is currently pursuing a Master’s in Statistics and Data Science, as well as a PhD. Jessica is deeply engaged in research focused on improving patient care, particularly in oncology and eating disorders. She is an author of several publications, including systematic reviews on chemotherapy toxicities, food insecurity, and binge eating. Her expertise extends to clinical trials and the development of innovative healthcare solutions, such as a smart swaddle for infants with neonatal abstinence syndrome. Jessica is committed to improving patient quality of life through her work as a graduate research assistant and peer reviewer.

Profile

Scopus

🎓 Education

University of Pennsylvania Bachelor of Nursing Science (BSN), 2023. Master of Statistics and Data Science, In Process. Doctor of Philosophy, In Process

💼 Experience

Graduate Research Assistant, University of Pennsylvania, 2021-Present Jessica leads research on diet interventions to alleviate chemotherapy toxicities, coordinates data for clinical trials, and manages a systematic review on food insecurity and binge eating. Peer Reviewer, European Journal of Oncology Nursing, 2024-Present Evaluates submissions for scientific rigor, providing feedback to improve clarity and validity. Penn Nursing Innovation Accelerator Awardee, 2022 Led a team to develop a smart swaddle for infants with neonatal abstinence syndrome, offering comfort and distress relief.

🏆 Awards & Honors

Best Review Paper, International Journal of Eating Disorders (2023) Recognized for outstanding scholarly work as an early career scholar. Rita and Alex Hillman Foundation Pilot Award ($5,000) Awarded for innovative healthcare research. Doctoral Student Organization Research Grant ($325) Provided funding to support academic research. Penn Nursing Innovation Accelerator Awardee ($2,500) Awarded for leading an innovation team developing a smart swaddle system. Eastern Nursing Research Society Annual Conference Abstract Presentation (2023) Presented impactful research findings.

🔬 Research Focus

Jessica’s research aims to improve patient outcomes through evidence-based interventions. She is particularly focused on the impact of diet on chemotherapy toxicities and quality of life, as well as the relationship between food insecurity and binge eating disorders. Additionally, she coordinates clinical trials and studies exploring the effects of lymphedema and fibrosis treatment. Her innovative work includes developing a smart swaddle system for infants with neonatal abstinence syndrome (NAS). Jessica’s research seeks to create practical solutions for complex health challenges and contribute to enhancing patient care in diverse clinical settings.

🏆Conclusion 

Jessica Abene’s combination of rigorous academic training, innovative research, and leadership in healthcare makes her a standout candidate for the Best Researcher Award. Her systematic reviews, dedication to improving patient quality of life, and groundbreaking work in the intersection of healthcare and technology reflect her potential to make significant contributions to the nursing field. Continuing to expand her research network and engaging more broadly with the community will further enhance her already impressive career trajectory.

Publication

  • Dietary Interventions for Alleviating Chemotherapy Toxicities in Patients with Cancer: A Systematic Review
    Year: 2024
    Authors: Abene, J. & Deng, J.
    Status: In process

 

  • Diet as an Adjunct Therapy in Reducing Chemotherapy Toxicities and Improving Patients’ Quality of Life: A Systematic Review and Meta-Analysis
    Year: 2024
    Authors: Abene, J., Tyburski, S., Kral, T. V. E., Quinn, R., & Deng, J.
    Journal: Nutrition and Cancer, 1–19
    DOI: 10.1080/01635581.2024.2437833

 

  • Food Insecurity and Binge Eating: A Systematic Review and Meta-Analysis
    Year: 2023
    Authors: Abene, J. A., Tong, J., Minuk, J., Lindenfeldar, G., Chen, Y., & Chao, A. M.
    Journal: The International Journal of Eating Disorders, 56(7), 1301–1322

 

  • Binge Eating Disorder and Eating Self-Efficacy in Adults Seeking Bariatric Surgery
    Year: 2022
    Authors: Chao, A. M., Abene, J., Allison, K. C., Pearl, R. L., Wadden, T. A., Williams, N. N., & Tronieri, J. S.
    Journal: Clinical Obesity, e12531
    DOI: 10.1111/cob.12531

 

  • The Importance of Student Nursing and Engineering Collaborations
    Year: 2022 (May 20)
    Authors: Leary, M., Abene, J.
    Journal: American Nurse

 

Fabiana Tortora | Cancer | Women Researcher Award

Dr. Fabiana Tortora | Cancer | Women Researcher Award 

Dr. Fabiana Tortora is a Postdoctoral Researcher at the Institute of Genetics and Biophysics (IGB-ABT), CNR, Naples, Italy. With expertise in molecular biology and biochemistry, her research focuses on protein interactors of long non-coding RNAs in bladder cancer and their therapeutic potential. She has presented at numerous international conferences and published extensively in peer-reviewed journals. Dr. Tortora’s work bridges molecular mechanisms and clinical applications, contributing to advancements in cancer research and environmental biochemistry.

Profile

Scopus

🎓 Education

Ph.D. in Biochemical and Biotechnological Sciences: University of Campania Luigi Vanvitelli (2019). Master’s Degree in Biology (LM-6): University of Naples “Federico II” (2016), graduated 110 cum laude. Undergraduate Training: Specialization in molecular biochemistry and precision medicine. Academic projects focused on antioxidant assays, DNA/RNA analysis, and apoptosis markers.

🧑‍🏫 Experience

Postdoctoral Fellow: AIRC-funded project on bladder cancer, IGB-ABT, CNR (2023-2026). Research Grant Recipient: IBP Institute, CNR, Naples (2020-2022). Visiting Scientist: Zewail City of Science and Technology, Egypt (2021). Internship: University of Tübingen, Germany (2018); Campania Luigi Vanvitelli (2016). Expertise in cell cultures, protein purification, FACS, and PCR.

🏆 Awards and Honors

Ph.D. Excellence: University of Campania Luigi Vanvitelli (2019).  Awarded 2022 AIRC Postdoctoral Fellowship for cancer research. Recognized for outstanding research presentations at international conferences. Cum Laude distinction for Master’s degree in Biology.

🔬 Research Focus

Bladder Cancer: Investigating long non-coding RNAs (uc.8+) and their diagnostic/therapeutic potential. Molecular Biochemistry: Protein-DNA/RNA interactions and apoptosis mechanisms. Antioxidant Research: Protective effects of hydroxytyrosol in oxidative stress and mercury detoxification. Techniques: In silico docking, cell/tissue cultures, ROS assays, and enzymatic kinetics.

🏆Conclusion 

Dr. Tortora’s academic rigor, technical proficiency, and impactful research contributions make her a strong contender for the Women Researcher Award. Her work addresses critical biomedical challenges, such as cancer diagnostics and environmental toxicology, underscoring her relevance in both clinical and ecological contexts. By broadening her collaborations and enhancing publication impact, Dr. Tortora can further solidify her position as a leading researcher. She exemplifies excellence in research and is well-suited for recognition through this prestigious award.

📚Publications 

  • Prediction of Pesticide Interactions with Proteins Involved in Human Reproduction by Using a Virtual Screening Approach: A Case Study of Famoxadone Binding CRBP-III and Izumo
    • Year: 2024
    • Authors: Tortora, F., Guerrera, V., Lettieri, G., Febbraio, F., Piscopo, M.

 

  • Emerging RNA-Based Therapeutic and Diagnostic Options: Recent Advances and Future Challenges in Genitourinary Cancers
    • Year: 2023
    • Authors: Tortora, F., La Civita, E., Trivedi, P., Terracciano, D., Cimmino, A.

 

  • CD33 rs2455069 SNP: Correlation with Alzheimer’s Disease and Hypothesis of Functional Role
    • Year: 2022
    • Authors: Tortora, F., Rendina, A., Angiolillo, A., Febbraio, F., Vitale, E.

 

  • Effects of long non-coding RNAs on androgen signaling pathways in genitourinary malignancies
    • Year: 2021
    • Authors: Tortora, F., Calin, G.A., Cimmino, A.

 

  • Liquid biopsy biomarkers in urine: A route towards molecular diagnosis and personalized medicine of bladder cancer
    • Year: 2021
    • Authors: Ferro, M., La Civita, E., Liotti, A., Cimmino, A., Terracciano, D.

 

  • Novel insights into mercury effects on hemoglobin and membrane proteins in human erythrocytes
    • Year: 2020
    • Authors: Piscopo, M., Notariale, R., Tortora, F., Palumbo, G., Manna, C.

 

  • Hydroxytyrosol decreases phosphatidylserine exposure and inhibits suicidal death induced by lysophosphatidic acid in human erythrocytes
    • Year: 2019
    • Authors: Tortora, F., Notariale, R., Lang, F., Manna, C.

 

  • Phenol-rich feijoa sellowiana (Pineapple guava) extracts protect human red blood cells from mercury-induced cellular toxicity
    • Year: 2019
    • Authors: Tortora, F., Notariale, R., Maresca, V., Piscopo, M., Manna, C.

 

  • Comparative analysis of the effects of olive oil hydroxytyrosol and its 5-S-lipoyl conjugate in protecting human erythrocytes from mercury toxicity
    • Year: 2018
    • Authors: Officioso, A., Panzella, L., Tortora, F., Napolitano, A., Manna, C.

 

Ayrton Bangolo | Oncology | Best Researcher Award

Dr. Ayrton Bangolo | Oncology | Best Researcher Award

Dr at Hackensack University Medical Center, United States

Dr. Ayrton I. Bangolo, MBBS, MD, is a board-certified internal medicine physician and current Hematology and Oncology fellow at Hackensack University Medical Center, New Jersey. With extensive medical training spanning across multiple countries, he graduated from Tianjin Medical University in China with an MBBS and gained ECFMG certification after excelling in USMLE exams. Dr. Bangolo has held significant positions in various esteemed medical institutions, including a residency at Palisades Medical Center, NJ. He has showcased his expertise through clinical practice, externships, and observerships in internal medicine, endocrinology, nephrology, and interventional radiology. His dedication to research and community health has been recognized with accolades such as awards at HMH research day. Dr. Bangolo’s background is enriched with a global perspective, which contributes to his comprehensive approach to patient care and medical innovation.

Profile

Scholar

Education 🎓

Ph.D. Fellowship in Hematology and Oncology (2024-Present): Hackensack University Medical Center, NJ, enrolled in an ACGME-accredited program. Residency in Internal Medicine (2021-2024): Palisades Medical Center, North Bergen, NJ, successfully completed a full-term ACGME-accredited residency. Transitional Year Residency (2020-2021): Palisades Medical Center, NJ, completed with exemplary performance. MBBS Degree (June 2016): Tianjin Medical University, China, graduated with credentials equivalent to MD. USMLE Certification: Passed USMLE Steps 1, 2 CK, and 3 on the first attempt, affirming ECFMG certification and eligibility for medical licensure in the U.S. Externships and Observerships: Clinical experience at Endocrine Associates, Norton’s Suburban Hospital, and Ngaliema Clinic among others, contributing to multidisciplinary expertise in internal medicine and specialty areas.

 Experience 💼

Hematology and Oncology Fellow (2024-Present): Hackensack University Medical Center, NJ, contributing to advanced clinical research and patient care in an ACGME-accredited fellowship. Internal Medicine Residency (2021-2024): Palisades Medical Center, North Bergen, NJ, completed core rotations with a focus on comprehensive patient care. Transitional Year Residency (2020-2021): Provided care across multiple medical disciplines at Palisades Medical Center, NJ. Externship in Endocrinology (2019-2020): Engaged in specialized practice under Dr. Hisham Alrefai at Endocrine Associates, KY. Observership in Nephrology (2019): Gained nephrology insights with Dr. Mohammed El Kheir at Norton’s Suburban Hospital, KY. Interventional Radiology Observership (2019): Participated under Dr. Mahmoud Samman, contributing to a deeper understanding of interventional procedures. Clinical Clerkship (2015-2016): Acquired foundational medical practice skills at Ngaliema Clinic, DR Congo.

Awards and Honors 🏆

2nd Place Research Poster: Honored for the study “Racial/Ethnic and Socioeconomic Differences in Colon Cancer Surgery” during the HMH North Region Fellow/Residents Research Day. UN Sustainable Development Goals Contribution: Published impactful research with Elsevier (2019-2021), emphasizing global health initiatives. Recognition for Excellence: Commended for clinical contributions during externships and observerships in Kentucky. Top Medical Graduate: Recognized as a distinguished graduate from Tianjin Medical University. USMLE Success: Passed all USMLE examinations on the first attempt, underscoring strong academic and practical medical knowledge.

Research Focus 🔍

Hematology & Oncology: Ongoing research in treatment protocols and health disparities, focusing on patient outcomes and innovative care practices. Racial and Socioeconomic Health Disparities: Investigated disparities in surgical treatments for colon cancer, contributing to policy discussions and medical strategies. Global Health Contributions: Published research aligning with United Nations’ goals, influencing international health practices. Medical Imaging & Diagnostics: Explored advancements in imaging for early disease detection and effective management. Endocrinology & Nephrology: Applied deep learning to medical data for better diagnostic outcomes and patient treatment plans. Patient Care & Clinical Innovation: Emphasizes integrative methods in patient treatment, fostering evidence-based and empathetic healthcare practices.

Conclusion 📝

Dr. Ayrton I. Bangolo’s proven track record in clinical practice, research contributions, and scholarly publications position him as a strong contender for the Best Researcher Award. His focus on impactful research and addressing health disparities is commendable. By expanding his research collaborations and further emphasizing his mentorship roles, Dr. Bangolo’s candidacy would be even more compelling.

Publications 📚

  • Title: Ultrasound performance using the EU-TIRADS score in the diagnosis of thyroid cancer in Congolese hospitals
    Authors: J Bukasa-Kakamba, P Bayauli, N Sabbah, J Bidingija, A Atoot, B Mbunga, …
    Year: 2022
    Journal: Scientific Reports 12 (1), 18442
    Citations: 9

 

  • Title: Racial/ethnic and socioeconomic differences in breast cancer surgery performed and delayed treatment: mediating impact on mortality
    Authors: P Fwelo, KOS Nwosu, TE Adekunle, O Afolayan, O Ahaiwe, AA Ojaruega, …
    Year: 2023
    Journal: Breast Cancer Research and Treatment 199 (3), 511-531
    Citations: 7

 

  • Title: Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States
    Authors: D Lew, F Kamal, K Phan, K Randhawa, S Cornwell, AI Bangolo, …
    Year: 2022
    Journal: World Journal of Clinical Oncology 13 (11), 907
    Citations: 7

 

  • Title: Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights
    Authors: AI Bangolo, C Trivedi, I Jani, S Pender, H Khalid, B Alqinai, A Intisar, …
    Year: 2023
    Journal: World Journal of Gastroenterology 29 (25), 3984
    Citations: 6

 

  • Title: Primary cardiac sarcoma: clinical characteristics and prognostic factors over the past 2 decades
    Authors: A Bangolo, P Fwelo, KM Iyer, S Klinger, L Tavares, S Dey, AA Chacko, …
    Year: 2023
    Journal: Diseases 11 (2), 74
    Citations: 6

 

  • Title: The overall quality of evidence of recommendations surrounding nutrition and diet in inflammatory bowel disease
    Authors: S Weissman, BM Fung, A Bangolo, A Rashid, BF Khan, AKG Tirumala, …
    Year: 2023
    Journal: International Journal of Colorectal Disease 38 (1), 98
    Citations: 6

 

  • Title: The Spectrum of Thyroid Nodules at Kinshasa University Hospital, Democratic Republic of Congo: A Cross-Sectional Study
    Authors: JK Bukasa, P Bayauli-Mwasa, BK Mbunga, A Bangolo, W Kavula, …
    Year: 2022
    Journal: International Journal of Environmental Research and Public Health 19 (23), 16203
    Citations: 6

 

  • Title: Outcomes of patients with gastrointestinal stromal tumors in the past decade
    Authors: A Bangolo, P Fwelo, T Al-Qatish, J Bukasa-Kakamba, T Lee, AG Cayago, …
    Year: 2023
    Journal: Medical Sciences 11 (3), 54
    Citations: 5

 

Angelika Długosz-Pokorska | cancer research | Women Researcher Award

 Dr. Angelika Długosz-Pokorska | cancer research |Women Researcher Award

 Dr at Medical University of Łódź,  Poland

A dedicated researcher and project leader at the Medical University of Lodz, Poland, with expertise in pharmacological characterization and anticancer drug development. As Principal Investigator and Co-investigator, led projects funded by prestigious grants like OPUS and SONATA, focusing on opioid peptide analogs and alpha-methylidene-delta-lactones. Supervising international student exchanges and engaging in expert activities, workshops, and editorial work. Recognized with numerous awards for scientific excellence, including Rector’s Awards and IF=8.638 for publication series on opioid mimetics and glutathione peroxidase. Committed to advancing medical science through innovative research and academic leadership.

Profile

  1. Scopus

 

  1. Orcid

📜 Employment History:

Research Associate (2017-present) Medical University of Lodz, Poland; Faculty of Medicine. Co-investigator (2016-2021)
Project: Rational design and pharmacological characterization of chimeric cyclic opioid peptide analogs targeting multiple receptors
Grant: OPUS 9, project ID 2015/17/B/ST5/00153. Principal Investigator (2016-2021) Project: Analysis of the anticancer activity of new synthetic alpha-methylidene-delta-lactones in selected cell lines Grant: SONATA, project ID 2015/17/D/NZ3/02226. Supervisor, Project Manager, and Principal Investigator (2018-present) Project: Analysis of the anticancer activity and molecular mechanism of action of new hybrid molecules containing uracil skeleton with an exo-cyclic methylene group Grant: PRELUDIUM13, project ID UMO-2017/25/N/NZ3/01039

📚 Short Research Training:

University of Rouen, France (2014) Laboratoire de Neuropsychopharmacologie Expérimentale

🌍 Activities:

  • Expert Activity/Reviewer (2024)
    Platform: Qeios
  • International Student Exchanges and ERASMUS Supervision (2024)
    Engaging in initiatives and participating in European Union programs, overseeing ERASMUS students.
  • Participation in Scientific Workshops and Research Teams (2024)
    Engaging in workshops aimed at exchanging experiences, self-improvement, and organization.
  • Editorial Work (2023-present)
    Journal: Reviewer for Breast Cancer-Tokyo, ISSN 1340-6868, eISSN 1880-4233.

🏆 Awards and Distinctions:

2022: First-level Special Award for Outstanding Didactic Work by Academic Teachers Medical University of Lodz.

2020: Team Distinction from the Faculty of Chemistry Nicolaus Copernicus University in Toruń Rector’s Award Medical University of Lodz Second-degree scientific award for a series of publications titled: ‘Investigation of the Anticancer Properties of Synthetic Analogues of Compounds Isolated from Plants’. (Impact Factor – 8.034). Polish Intelligent Development Award – Nomination.

2019: Investigation of Anticancer Activity of Synthetic Analogues of Methylenolactones”, IF=4.026PTBioch Bursary Scholarship 44th FEBS Congress “From Molecules to Living Systems”. Rector’s Award Medical University of Lodz Second Prize for Publication: ‘Synthetic Analogues of Coumarin as Novel Agents with Anticancer Activity’. (Impact Factor = 4.173). Rector’s Award Medical University of Lodz Team Second award for Publication Series:

2017: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Synthesis and Investigation of Biological Activity of Opioid Mimetics and Glutathione Peroxidase”. (IF=8.638). Rector’s Award Medical University of Lodz Team First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Dicoumarins”. (IF=6.221) “Investigation of Anticancer Activity of Sesquiterpene Lactones”. (IF=4.994)

2016: Rector’s Award Medical University of Lodz First Prize for Publication Series: “Anticancer Properties of Novel Synthetic Lactones in Combination with Known Anticancer Drugs”. (IF = 8.835)

Publications Top Notes 📝

  • Title: Synthesis of New Chiral β-Carbonyl Selenides with Antioxidant and Anticancer Activity Evaluation-Part I
    • Authors: Laskowska, A., Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., et al.
    • Journal: Materials
    • Year: 2024
    • Volume: 17
    • Pages: 1–15
    • Summary: This study focuses on the synthesis of new chiral β-carbonyl selenides and evaluates their antioxidant and anticancer activities, providing valuable insights into potential therapeutic agents.

 

  • Title: New Uracil Analog with Exocyclic Methylidene Group Can Reverse Resistance to Taxol in MCF7 Cancer Cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Biologics: Targets and Therapy
    • Year: 2023
    • Volume: 17
    • Pages: 69–83
    • Summary: This article presents a novel uracil analog with potential to reverse resistance to Taxol in MCF7 cancer cells, indicating its promising role as an anticancer agent.

 

  • Title: New Uracil Analog- U-359 can Reverse Resistance to Taxol in MCF-7 cancer cells
    • Authors: Długosz-Pokorska, A., Perlikowska, R., Janecki, T., et al.
    • Journal: Acta Biochimica Polonica
    • Year: 2023
    • Volume: 70
    • Pages: 56
    • Summary: This study explores another uracil analog’s potential to reverse resistance to Taxol in MCF-7 cancer cells, indicating a promising avenue for further research.

 

  • Title: The Influence of Long Carbon Chains on the Antioxidant and Anticancer Properties of N-Substituted Benzisoselenazolones and Corresponding Diselenides
    • Authors: Pacuła-Miszewska, A.J., Obieziurska-Fabisiak, M., Jastrzębska, A., et al.
    • Journal: Pharmaceuticals
    • Year: 2023
    • Volume: 16
    • Pages: 1–11
    • Summary: This research investigates the impact of long carbon chains on the antioxidant and anticancer properties of N-substituted benzisoselenazolones and corresponding diselenides, providing valuable insights into structure-activity relationships.

 

  • Title: Attachment of Chiral Functional Groups to Modify the Activity of New GPx Mimetics
    • Authors: Laskowska, A., Pacuła-Miszewska, A., Długosz-Pokorska, A., et al.
    • Journal: Materials
    • Year: 2022
    • Volume: 16
    • Pages: 1–14
    • Summary: This study explores the modification of GPx mimetics’ activity through the attachment of chiral functional groups, offering potential strategies for enhancing therapeutic effects.

 

Ebru Temiz | cancer research | Best Researcher Award

Assist Prof Dr . Ebru Temiz | cancer research | Best Researcher Award

👨‍🏫Profile Summary

A dedicated academic and researcher in the field of Medical Biology and Genetics, with extensive experience in cancer research and therapeutic investigations. Holds a Ph.D. and Master’s degree from Gaziantep University, specializing in miRNA and lncRNA therapies for cancer treatment. Currently serving as a faculty member at Harran University, contributing to educational programs and leading various research projects. Proficient in project management, molecular biology techniques, and data analysis. Passionate about advancing medical science and making meaningful contributions to cancer therapy.

🌐 Professional Profiles

📚 Education Information

🎓 PhD in Medical Biology and Genetics Institution: Gaziantep University, Medical Faculty Department: Medical Biology and Genetics Thesis Title: Investigation of the Therapeutic Effects of miRNAs Targeting CCT3 Gene in Various Cancer Cell Lines Date: 01 September 2016 – 01 November 2020 (4 Years 3 Months) Thesis Advisor: Professor Emel Şahin 🎓 Master’s Degree in Medical Biology and Genetics Institution: Gaziantep University, Medical Faculty Department: Medical Biology and Genetics Thesis Title: Investigation of the Therapeutic Effect of PINK1-AS lncRNA in HCT116 Colon Cancer Cell Line Date: 01 September 2013 – 01 June 2016 (2 Years 10 Months) Thesis Advisor: Professor Serdar Oztuzcu 🎓 Bachelor’s Degree in Biology Institution: Gaziantep University Date: 01 September 2008 – 26 June 2012 (3 Years 10 Months) Cumulative Grade Point Average: 3.21 / 4.0

📝 Experience Information

👨‍🏫 Faculty Member, Dr. Institution: Harran University Şanlıurfa Health Services Vocational School Department: Medical Services and Techniques, Medical Promotion and Marketing Program Date: 07 September 2022 – Present (11 Months) 👨‍🏫 Faculty Member Institution: Harran University Şanlıurfa Health Services Vocational School Department: Medical Services and Techniques, Medical Promotion and Marketing Program Date: 09 March 2017 – Present (6 Years 5 Months) 👨‍🔬 PhD Fellow Institution: Gaziantep University Date: 01 January 2013 – 01 January 2017 (4 Years 1 Month)

📚 Competency

📖 Books Title: Cancer Genetics Authors: E. Temiz, R. Dikme, A. Sarpkaya, D. Taşdemir, C. Okudu, . Bozgeyik & E. Bozgeyik Publication: Nobel Publication, Turkey Date: 01 December 2021 Chapter In Book

🔬 Projects

Investigation Of Mmh-1’s Anti-Cancer Effect In 4T1 Breast Cancer Mouse Model Position: Project Manager Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Investigation Of The Protective Effects Of Green Pistachio (Pistacia Vera L.) Shell Extract On The Heart In Rats With Doxorubicin-Induced Cardiac Damage Position: Researcher Institution: Medical Faculty Sponsor Institution: Harran University (Domestic) Status: Ongoing Protective Effects Of Fusilin On Heart Damage Induced By Dobutamine In Rats Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Effects Of Myo-Inositol And Oxytetracycline Added To The Diluter On Sperm Quality After Thawing Of Frozen Sperm Of Barbus Grypus Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Status: Ongoing Investigation Of Therapeutic Effects Of miRNAs Targeting CCT3 Gene In Various Cancer Cell Lines Position: Researcher Institution: Gaziantep University Sponsor Institution: Gaziantep University (Domestic) Date: 01 May 2019 – 01 November 2020 Investigation Of The Potential Use Of Green Antep Pistachio Shell As A Phytotherapeutic And Dietary Supplement Product Position: Researcher Institution: Harran University Sponsor Institution: Development Ministry (Domestic) Date: 01 February 2019 – 01 May 2020 Evaluation Of Polymorphisms In CX3CR1, UQCC And BMP-2 Genes And miR-96 Expression In Patients With Developmental Hip Dysplasia (DHD) Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 October 2018 – 01 October 2019 Investigation Of The Anticancer Effect Of Haplophyllum Ptilostylum Plant On Liver Cancer (SNU-423) Cells Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 July 2018 – 01 February 2019 Change In Micro-RNA During Cardiopulmonary Bypass Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 February 2018 – 01 February 2019 Investigation Of Tissue And Plasma Free Amino Acid And Carnitine Profile In Patients With Pterygium Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 January 2018 – 01 January 2019 Equation With Three Unknowns In The Pericardial Fluid And Plasma Of Patients Undergoing Open Heart Surgery: Interleukin 33 (IL33), Fetuin A, And Cytokeratin 18 Relationship Position: Researcher Institution: Harran University Sponsor Institution: Harran University (Domestic) Date: 01 February 2017 – 01 April 2018

📚Top Noted Publication

  1. Title: Cardioprotective Effect Of Pistacia Vera L.(Green Pistachio) Hull Extract In Wistar Albino Rats With Doxorubicin-Induced Cardiac Damage
    • Authors: Ersöz, M. S., Aydin, Y., Hacanli, N., Kankiliç, N., Koyuncu, ., Güldür, M. E., Temiz, E., Çakmak, Y., Eč, K., Dikme, R., Padak, M.
    • Journal: Anatolian Journal Of Cardiology
    • Year: 2023
    • Volume: 27
    • Issue: 3
    • Pages: 2149-2263

 

  1. Title: Local Myelin Damage In The Hippocampus Fluctuates Gut Microbiome Profile And Memory
    • Authors: Bostancıoğlu, M., Kaplan, D. S., Temiz, E., Y, G. T.
    • Journal: Journal Of Psychiatric Research
    • Year: 2023
    • Volume: 158
    • Pages: 392-402

 

  1. Title: Novel Zinc Oxide Nanoparticles Of Teucrium Polium Suppress The Malignant Progression Of Gastric Cancer Cells Through Modulating Apoptotic Signaling Pathways And Epithelial To Mesenchymal Transition
    • Authors: Elmastaş, E., Temiz, E., Koyuncu, ., Erdal, B., Koyuncu, ., Tem Z, C., Bozgeyik, E.
    • Journal: Gene
    • Year: 2023
    • Volume: 853
    • Pages: 147091

 

  1. Title: Protective Effects Of Fuziline On Dobutamine-Induced Heart Damage In Mice
    • Authors: Hacanli, Y., Aydin, M. S., Ersöz, E. K., Kankiliç, N., Koyuncu, ., Güldür, M. E., Temiz, E., Dikme, R., Eč, K., Çakmak, Y., Padak, M.
    • Journal: Brazilian Journal Of Cardiovascular Surgery
    • Year: 2023
    • Volume: 38
    • Issue: 1
    • Pages: E20220251

 

  1. Title: Asprosin And Oxidative Stress Level In Covid-19 Patients
    • Authors: Seyhanlı, E. S., Koyuncu, I., Yasak, I. H., Dem, H. R., Temiz, E.
    • Journal: Clinical Laboratory
    • Year: 2022
    • Volume: 68
    • Issue: 1
    • Pages: 1-6

 

  1. Title: Cedrus Libani Tar Prompts Reactive Oxygen Species Toxicity And Dna Damage In Colon Cancer Cells
    • Authors: Temiz, E., Eg, K., Koyuncu, I., Yuksekdag, O., Kurt, Y., Ken, M. T., Akmese, S.
    • Journal: Molecular Biology Reports
    • Year: 2022
    • Volume:
    • Pages:
    • DOI: 0301-4851

 

  1. Title: Examination Of Carnitine Metabolism In Different Breast Cancer Cell Lines
    • Authors: Akmeşe, Ş., Temiz, E., Koyuncu, ., Taşkıran, H., Tüysüz, M. Z.
    • Journal: Harran University Medical Faculty Journal
    • Year: 2022
    • Volume: 19
    • Issue: 1
    • Pages: 1-7

 

  1. Title: Intracellular Ph-Mediated Induction Of Apoptosis In Hela Cells By A Sulfonamide Carbonic Anhydrase Inhibitor
    • Authors: Koyuncu, I., Temiz, E., Durgun, M., Kocy G T, A., Yuksekdag, O., Supuran, C. T.
    • Journal: International Journal Of Biological Macromolecules
    • Year: 2022
    • Volume: 201
    • Pages: 37-46

 

  1. Title: Examination Of The Anticancer Activity Of Pecan (Carya Illinoensis) Shell
    • Authors: Akkafa, F., Hayırlı, Z., Temiz, E., Koyuncu, .
    • Journal: Harran University Medical Faculty Journal
    • Year: 2022
    • Volume: 19
    • Issue: 1
    • Pages: 131-136

 

  1. Title: Silencing Of Tp73-As1 Impairs Prostate Cancer Cell Proliferation And Induces Apoptosis Via Regulation Of Tp73
  • Authors: Arslan, A., Batar, B., Temiz, E., Tozk R, H., Koyuncu, I., Bozgeyik, E.
  • Journal: Molecular Biology Reports
  • Year: 2022
  • Volume: 49
  • Issue: 7
  • Pages: 6859-6869